drugset / Trial / NCT00064649
Minimally Invasive Surgical Therapy for BPH
Phase 3
Terminated
49 enrolled
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Diagnostic Ultrasound · collabMedtronic · collabMerck Sharp & Dohme LLC · collabSanofi-Synthelabo · collabUrologix · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The primary objective of this randomized clinical trial is to determine the efficacy and safety of three treatments for benign prostatic hyperplasia (BPH): transurethral needle ablation (TUNA), transurethral microwave therapy (TUMT), and medical therapy with alfuzosin and finasteride.
Timeline
- Start
- 2004-04
- Primary completion
- —
- Completion
- 2006-06
Outcome
Outcome not reported
Stopped (Enrollment): “Inability to recruit required sample size.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Alfuzosin | Small molecule | 10 mg | — |
| Comparator | Finasteride | Small molecule | 5 mg | — |